Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | CES2 | O00748 | 1/20 | 0.36 |
| ▸ | CES1 | P23141 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.35 |
| ▸ | RELA | Q04206 | 1/20 | 0.35 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.35 |
| ▸ | HTR2C | P28335 | 1/20 | 0.34 |
| ▸ | HTR2B | P41595 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 2/20 | 0.34 |
| ▸ | BACE1 | P56817 | 1/20 | 0.34 |
| ▸ | DAO | P14920 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11029574 | 0.97 | TAAR1 (0.41) | TAAR1KDM4EGAAALDH1A1SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL29184016 | 0.97 | TAAR1 (0.41) | TAAR1KDM4EGAAALDH1A1SMN1; SMN2 | |
| Acetonitrile SCHEMBL16963780 | 0.86 | KDM4E (0.38) | TAAR1KDM4EGAAALDH1A1SMN1; SMN2 | |
| SCHEMBL4243083 | 0.85 | EED (0.41) | TAAR1KDM4EGAAALDH1A1SMN1; SMN2 | |
| SCHEMBL3304485 | 0.85 | TAAR1 (0.38) | TAAR1KDM4EGAAALDH1A1SMN1; SMN2 | |
| SCHEMBL29386736 | 0.85 | EED (0.41) | TAAR1KDM4EGAAALDH1A1SMN1; SMN2 | |
| SCHEMBL18984003 | 0.84 | GABRA1 (0.46) | TAAR1KDM4EALDH1A1SMN1; SMN2HTT | |
| SCHEMBL7997992 | 0.83 | TAAR1 (0.41) | TAAR1KDM4EGAAALDH1A1SMN1; SMN2 | |
| SCHEMBL15071663 | 0.83 | ACHE (0.48) | TAAR1KDM4EGAAALDH1A1SMN1; SMN2 | |
| SCHEMBL19443767 | 0.83 | TAAR1 (0.36) | TAAR1KDM4EGAAALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1485 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4634195-A1 | PROCESS FOR THE PREPARATION OF RELUGOLIX | Medichem, S.A. (ES) | 2025-10-22 | — | — | EP | claimed |
| CN-119546611-A | Preparation process and intermediate of rui Lu Geli | 台湾神隆股份有限公司 | 2025-02-28 | — | — | CN | claimed |
| CN-119465288-A | Anion exchange membrane, preparation method and application thereof, and electrolysis device | 氢和元泰(常州)新材料科技有限公司 | 2025-02-18 | — | — | CN | claimed |
| WO-2024126674-A1 | PROCESS FOR THE PREPARATION OF RELUGOLIX | MEDICHEM, S.A. (ES) | 2024-06-20 | — | — | WO | claimed |
| CN-117820161-A | Synthesis method of Lu Fei amide intermediate 2-azidomethyl-1, 3-difluorobenzene | 万特制药(海南)有限公司 | 2024-04-05 | — | — | CN | claimed |
| US-20230357267-A1 | PROCESS FOR PREPARING RELUGOLIX AND INTERMEDIATES THEREOF | SCINOPHARM TAIWAN, LTD. (TW) | 2023-11-09 | — | — | US | claimed |
| WO-2023214935-A1 | PROCESS FOR PREPARING RELUGOLIX AND INTERMEDIATES THEREOF | SCINOPHARM TAIWAN, LTD. (TW) | 2023-11-09 | — | — | WO | claimed |
| CN-112473396-B | Anion exchange membrane material for diffusion dialysis acid recovery and preparation method thereof | 西安建筑科技大学 | 2022-06-24 | — | — | CN | claimed |
| WO-2021047572-A1 | GSK-3β/CHE DOUBLE INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF | 中国药科大学 | 2021-03-18 | — | — | WO | claimed |
| CN-112473396-A | Anion exchange membrane material for diffusion dialysis acid recovery and preparation method thereof | 西安建筑科技大学 | 2021-03-12 | — | — | CN | claimed |
| CN-107089913-B | 2-substituted methyl rupestonic acid derivative and preparation method and application thereof | 中国科学院新疆理化技术研究所 | 2020-10-09 | — | — | CN | claimed |
| US-20170348258-A1 | 3-Amino Benzamide Derivative Serving As B-Lactam Auxiliary Antibiotic, Preparation Method and Use Thereof | THE HONG KONG POLYTECHNIC UNIVERSITY (CN) | 2017-12-07 | — | — | US | claimed |
| CN-104245692-B | Industrial process for the preparation of high purity methzolin | 牧牛研究所株式会社 | 2016-08-24 | — | — | CN | claimed |
| CN-105461585-A | 3-aminobenzamide derivative as beta-lactam auxiliary antibiotic, preparation method and application | UNIV HONG KONG POLYTECHNIC | 2016-04-06 | — | — | CN | claimed |
| CN-104245692-A | Industrial process for the preparation of high purity methzolin | MOGHU RES CT LTD | 2014-12-24 | — | — | CN | claimed |
| CN-103539750-A | Synthesis process of rufinamide | XUHE TIANJIN MEDICINE SCIENCE & TECHNOLOGY CO LTD | 2014-01-29 | — | — | CN | claimed |
| CN-122080069-A | Phospholipid compounds and uses thereof | — | 2026-05-26 | — | — | CN | disclosed |
| US-12606564-B2 | Adenosine receptor antagonist compounds | ILDONG PHARMACEUTICAL CO., LTD. (KR) | 2026-04-21 | — | — | US | disclosed |
| US-4695579-A | Antifungal 2-azolylmethyl-3-difluorobenzyloxy-2,3-dihydrofluoro-benzo(B) thiophens | SCHERING CORPORATION (US) | 1987-09-22 | — | — | US | disclosed |
| EP-0185381-A2 | 2-Azolylmethyl-3-difluorobenzyloxy-2,3-dihydrofluorobenzo(b)thiophenes, process for their preparation and compositions containing them | SCHERING CORPORATION (US) | 1986-06-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170348258-A1 | 3-Amino Benzamide Derivative Serving As B-Lactam Auxiliary Antibiotic, Preparation Method and Use Thereof | BCAT2, SBDS, BCAT1 | TAAR1 4348/4885KDM4E 1472/4885GAA 679/4885 |
| US-12606564-B2 | Adenosine receptor antagonist compounds | ADORA2A, ADORA1, ADORA2B | TAAR1 88/4885KDM4E 4084/4885GAA 3007/4885 |
| US-20230357267-A1 | PROCESS FOR PREPARING RELUGOLIX AND INTERMEDIATES THEREOF | PRMT8, PRMT7, PRMT1 | TAAR1 1061/4885KDM4E 26/4885GAA 1691/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.